Specifically, rates of HR-positive and ERBB2-negative breast cancer are generally increasing, while in more recent years rates of HR-positive and ERBB2-positive and HR-negative and ERBB2-positive cancers are decreasing. The gene discussed is ERBB2; the disease is breast carcinoma.